News Channels

08 Sep 2020 AVEO Oncology Regains Full Global Rights to Ficlatuzumab
08 Sep 2020 Atara Biotherapeutics Announces FDA Clearance of IND for ATA2271, a Next-Generation Autologous Mesothelin-Targeted CAR T with Novel PD1DNR and 1XX Technologies Combined to Treat Solid Tumors
08 Sep 2020 Caribou Biosciences Announces FDA Clearance of its IND for CB-010, an Off-the-shelf Allogeneic Anti-CD19 CAR-T Cell Therapy
08 Sep 2020 Goldfinch Bio Initiates Phase 2 Clinical Trial Evaluating Novel Drug Candidate GFB-887 as a Precision Medicine for Patients with Kidney Diseases
08 Sep 2020 Exelixis and Catalent Enter into Collaboration, License, and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leveraging SMARTag® Bioconjugation Technology
08 Sep 2020 Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
08 Sep 2020 Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen)
08 Sep 2020 Merck’s Gefapixant (45 mg Twice Daily) Significantly Decreased Cough Frequency Compared to Placebo at Week 12 and 24 in Patients with Refractory or Unexplained Chronic Cough
08 Sep 2020 SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19
08 Sep 2020 Zion Pharma Announces Initiation of Phase 1 Study
08 Sep 2020 Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine
08 Sep 2020 Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553
07 Sep 2020 Janssen Announces European Commission Decision for Expanded Use of IMBRUVICA® (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukaemia (CLL)
07 Sep 2020 IcanoMAB GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19
07 Sep 2020 Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome
07 Sep 2020 Boehringer Ingelheim Discontinues Development of BI 1467335 for Diabetic Retinopathy
05 Sep 2020 Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-1 Phase 2 Clinical Study of LX9211 in Patients With Diabetic Peripheral Neuropathic Pain
05 Sep 2020 Arcturus Therapeutics Announces Preclinical Publication of its COVID-19 Vaccine Candidate
05 Sep 2020 Kite Submits Supplemental Biologics License Application to U.S. Food and Drug Administration for Yescarta® in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas
05 Sep 2020 AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up